The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

May. 28, 2021
Applicants:

Shanghai Zhongze Therapeutics, Co. Ltd., Shanghai, CN;

Shanghai Institute of Pharmaceutical Industry, Shanghai, CN;

Inventors:

Jianqi Li, Shanghai, CN;

Yangli Qi, Shanghai, CN;

Xiaowen Chen, Shanghai, CN;

Junwei Xu, Shanghai, CN;

Ruixiang Yuan, Shanghai, CN;

Qiang Pu, Shanghai, CN;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 213/74 (2006.01); C07D 213/87 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
C07D 213/74 (2013.01); C07D 213/87 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 409/14 (2013.01);
Abstract

Disclosed in the present invention are a pyridinyl morpholine compound, a preparation method therefor, and an application thereof. The present invention provides a pyridinyl morpholine compound as represented by formula I, a pharmaceutically acceptable salt thereof or a hydrate of the pharmaceutically acceptable salt thereof. The compound can be used as an antagonist for one or more of D, Dor 5-HT, and is used for preparing a drug for treating schizophrenia.


Find Patent Forward Citations

Loading…